
Overview
Sawa Ito, MD, PhD, specializes in hematology oncology and medical oncology and is board-certified by the American Board of Internal Medicine. She practices at UPMC Hillman Cancer Center and is affiliated with UPMC Presbyterian, UPMC Magee-Womens Hospital, and UPMC Shadyside. Dr. Ito received her medical degree from Hokkaido University and completed residencies at Teine Keijinkai Hospital and the University of Pittsburgh School of Medicine, followed by a fellowship at the National Institutes of Health.
Dr. Ito is highly rated in 6 conditions, according to our data. Her top areas of expertise are Graft Versus Host Disease (GvHD), Multiple Myeloma, Leukemia, Bone Marrow Transplant, and Bone Marrow Aspiration.
Her clinical research consists of co-authoring 48 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- MANAGED MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
Locations
5115 Centre Avenue, Hillman Cancer Center, Pittsburgh, PA 15232
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
3 Clinical Trials
UPMC Hillman Cancer Center
Melissa Burgess, MD, is an assistant professor at the University of Pittsburgh School of Medicine and a medical oncologist. She specializes in the treatment of soft tissue and bone sarcomas and Merkel cell carcinoma. Dr. Burgess is highly rated in 42 conditions, according to our data. Her top areas of expertise are Adult Soft Tissue Sarcoma, Liposarcoma, Merkel Cell Carcinoma, Chondrosarcoma, and Gamma Knife Radiosurgery.
UPMC Hillman Cancer Center
Adam M. Brufsky, MD, PhD, FACP, is professor of medicine at the University of Pittsburgh School of Medicine and also serves as the associate division chief for the Division of Hematology/Oncology at the University of Pittsburgh School of Medicine's Department of Medicine. Dr. Brufsky is the medical director of the Magee-Women's Cancer Program, part of the UPMC Hillman Cancer Center, and UPMC Hillman Cancer Center; associate director for clinical investigations at UPMC Hillman Cancer Center; and codirector of the Comprehensive Breast Cancer Center.Dr. Brufsky is board-certified in internal medicine and medical oncology. He earned a medical and doctor of philosophy degrees from the University of Connecticut School of Medicine in Farmington, Conn.; completed a residency at Brigham and Women's Hospital, Harvard Medical School, and a fellowship at Dana-Farber Cancer Institute.Dr. Brufsky is a member of professional organizations, such as American Medical Association, Massachusetts Medical Society, American College of Physicians, American Society of Clinical Oncology, American Association for Cancer Research, Allegheny County Medical Society, Pennsylvania Medical Society, and Pennsylvania Oncologic Society. An active researcher, Dr. Brufsky has numerous abstracts and research articles in leading journals, and is principal investigator on a number of research grants funded by the National Institutes of Health, Susan G. Komen Foundation, and US Army - Breast Cancer Research Program. Dr. Brufsky is highly rated in 14 conditions, according to our data. His top areas of expertise are Breast Cancer, Triple-Negative Breast Cancer, Inflammatory Breast Cancer, Breast Cancer in Men, and Gastrostomy.
UPMC Hillman Cancer Center
Liza C. Villaruz, MD, is board-certified in medical oncology and hematology at UPMC Hillman Cancer Center, and she specializes in lung cancer and thoracic malignancies. Dr. Villaruz is highly rated in 13 conditions, according to our data. Her top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, EGFR Positive Lung Cancer, and Small Cell Lung Cancer (SCLC).
Frequently Asked Questions about Dr. Sawa Ito
How do I make an appointment with Dr. Sawa Ito?
You can book an appointment with Dr. Sawa Ito by calling their office at 412-946-2861. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Sawa Ito a top-rated expert for Graft Versus Host Disease (GvHD)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Sawa Ito is classified as an Distinguished expert for Graft Versus Host Disease (GvHD), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Sawa Ito specialize in?
While Dr. Sawa Ito is a Hematology Oncology, they have specific expertise in Graft Versus Host Disease (GvHD), Bone Marrow Transplant, and Multiple Myeloma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology Oncology.
Does Dr. Sawa Ito participate in research or clinical trials?
Yes. Dr. Sawa Ito has published 48 articles and abstracts on conditions like Graft Versus Host Disease (GvHD). You can view a list of Dr. Sawa Ito's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Sawa Ito accept my insurance?
Dr. Sawa Ito accepts most major insurance plans, including Aetna and Cigna. We recommend calling the office directly at 412-946-2861 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Bone Marrow TransplantDr. Ito isDistinguished. Learn about Bone Marrow Transplant.
- Graft Versus Host Disease (GvHD)Dr. Ito isDistinguished. Learn about Graft Versus Host Disease (GvHD).
- Advanced
- Acute Myeloid Leukemia (AML)
- Chronic Graft Versus Host Disease (cGvHD)
- LeukemiaDr. Ito isAdvanced. Learn about Leukemia.
- Multiple MyelomaDr. Ito isAdvanced. Learn about Multiple Myeloma.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Adult T-Cell LeukemiaDr. Ito isExperienced. Learn about Adult T-Cell Leukemia.
- AnemiaDr. Ito isExperienced. Learn about Anemia.
- Aplastic AnemiaDr. Ito isExperienced. Learn about Aplastic Anemia.



